Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Pregabalin	241
Overall Study	STARTED	Gabapentin	241
Overall Study	Completed Titration Phase	Pregabalin	213
Overall Study	Completed Titration Phase	Gabapentin	210
Overall Study	Completed Maintenance Phase	Pregabalin	187
Overall Study	Completed Maintenance Phase	Gabapentin	172
Overall Study	Entered Opt Blinded Continuation Phase	Pregabalin	140
Overall Study	Entered Opt Blinded Continuation Phase	Gabapentin	139
Overall Study	COMPLETED	Pregabalin	58
Overall Study	COMPLETED	Gabapentin	62
Overall Study	NOT COMPLETED	Pregabalin	183
Overall Study	NOT COMPLETED	Gabapentin	179

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00537940/flow